Lytras Theodore
School of Medicine, European University Cyprus, Engomi, Cyprus.
JMIRx Med. 2024 Jun 10;5:e43341. doi: 10.2196/43341.
Our previous analysis showed how in-hospital mortality of intubated patients with COVID-19 in Greece is adversely affected by patient load and regional disparities.
We aimed to update this analysis to include the large Delta and Omicron waves that affected Greece during 2021-2022, while also considering the effect of vaccination on in-hospital mortality.
Anonymized surveillance data were analyzed from all patients with COVID-19 in Greece intubated between September 1, 2020, and April 4, 2022, and followed up until May 17, 2022. Time-split Poisson regression was used to estimate the hazard of dying as a function of fixed and time-varying covariates: the daily total count of intubated patients with COVID-19 in Greece, age, sex, COVID-19 vaccination status, region of the hospital (Attica, Thessaloniki, or rest of Greece), being in an intensive care unit, and an indicator for the period from September 1, 2021.
A total of 14,011 intubated patients with COVID-19 were analyzed, of whom 10,466 (74.7%) died. Mortality was significantly higher with a load of 400-499 intubated patients, with an adjusted hazard ratio (HR) of 1.22 (95% CI 1.09-1.38), rising progressively up to 1.48 (95% CI 1.31-1.69) for a load of ≥800 patients. Hospitalization away from the Attica region was also independently associated with increased mortality (Thessaloniki: HR 1.22, 95% CI 1.13-1.32; rest of Greece: HR 1.64, 95% CI 1.54-1.75), as was hospitalization after September 1, 2021 (HR 1.21, 95% CI 1.09-1.36). COVID-19 vaccination did not affect the mortality of these already severely ill patients, the majority of whom (11,944/14,011, 85.2%) were unvaccinated.
Our results confirm that in-hospital mortality of severely ill patients with COVID-19 is adversely affected by high patient load and regional disparities, and point to a further significant deterioration after September 1, 2021, especially away from Attica and Thessaloniki. This highlights the need for urgent strengthening of health care services in Greece, ensuring equitable and high-quality care for all.
我们之前的分析表明,希腊新冠肺炎插管患者的院内死亡率如何受到患者负荷和地区差异的不利影响。
我们旨在更新这一分析,纳入2021 - 2022年期间影响希腊的德尔塔和奥密克戎大流行浪潮,同时考虑疫苗接种对院内死亡率的影响。
对2020年9月1日至2022年4月4日期间在希腊插管的所有新冠肺炎患者的匿名监测数据进行分析,并随访至2022年5月17日。采用时间分割泊松回归来估计死亡风险,将其作为固定和随时间变化的协变量的函数:希腊新冠肺炎插管患者的每日总数、年龄、性别、新冠肺炎疫苗接种状况、医院所在地区(阿提卡、塞萨洛尼基或希腊其他地区)、是否在重症监护病房,以及自2021年9月1日起的时间段指标。
共分析了14,011例新冠肺炎插管患者,其中10,466例(74.7%)死亡。插管患者负荷为400 - 499例时,死亡率显著更高,调整后的风险比(HR)为1.22(95%CI 1.09 - 1.38),当负荷≥800例时,该比值逐渐上升至1.48(95%CI 1.31 - 1.69)。在阿提卡地区以外住院也与死亡率增加独立相关(塞萨洛尼基:HR 1.22,95%CI 1.13 - 1.32;希腊其他地区:HR 1.64,95%CI 1.54 - 1.75),2021年9月1日之后住院也是如此(HR 1.21,95%CI 1.09 - 1.36)。新冠肺炎疫苗接种并未影响这些已患重病患者的死亡率,其中大多数(11,944/14,011,85.2%)未接种疫苗。
我们的结果证实,新冠肺炎重症患者的院内死亡率受到高患者负荷和地区差异的不利影响,并表明2021年9月1日之后情况进一步显著恶化,尤其是在阿提卡和塞萨洛尼基以外地区。这凸显了希腊迫切需要加强医疗服务,确保为所有人提供公平和高质量的护理。